Calcitonin before scan to improve parathyroid detection
Treatments studied
Part of Hormones & metabolism clinical trials.
This study looks at whether taking calcitonin before a special parathyroid scan (SPECT-CT) makes the scan easier to read. It’s for people with primary hyperparathyroidism who want surgery, and may help doctors find the right gland more reliably.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have primary hyperparathyroidism (not a different type caused by another condition).
- You had a non-localizing SPECT-CT scan within the last 12 months (the first scan didn’t clearly find the gland).
- You want surgery as treatment for your condition.
- Your blood calcium was at least 10.5 mg/dL before the first scan.
- You can safely receive the scan tracer and calcitonin (no known allergy/contraindications).
- You can avoid pregnancy during the study and can give research consent for a second scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special PET scan to better locate overactive parathyroid glands before surgery. It may help guide treatment for people with primary hyperparathyroidism.
This study tests two advanced imaging techniques (PET/MR and PET/CT) to find overactive parathyroid glands or tumors that need surgery. Participants get a special scan before surgery to help surgeons locate the problem more accurately.
This study compares a newer type of scan (18F-choline PET/CT) to standard imaging to help doctors locate overactive parathyroid glands. The goal is to see if the newer scan works better for planning surgery in people with primary hyperparathyroidism.
This trial tests whether a special scan (Choline PET/CT) can replace a blood test done during surgery (PTH) to guide treatment for primary hyperparathyroidism, making surgery simpler.
This study tests whether giving a bisphosphonate (a bone-strengthening drug) before parathyroid surgery helps protect bone health in people with primary hyperparathyroidism. It's for those who already have thin bones and are planning surgery.
This study compares a Sestamibi scan (with a special camera) versus a Fluorocholine scan (with PET/CT) to see which one better finds a suspected parathyroid adenoma. If your tests suggest a parathyroid problem but the first Sestamibi scan is negative or unclear, this trial may help answer the next best scan choice.
Hear when a new Primary Hyperparathyroidism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.